Valeant adjusted profit beats Street, but net loss widens

(Reuters) - Canada's Valeant Pharmaceuticals International Inc reported a better-than-expected quarterly profit on Tuesday, helped by lower costs and strength in its Bausch and Lomb eyecare business, but its net loss widened and the company said it was feeling pricing pressure.

Valeant adjusted profit beats Street, but net loss widens
Read More


Bagikan Berita Ini